Cover Image
市場調查報告書

全球骨·關節的再生醫療市場:產業分析·規模·佔有率·成長率與趨勢與預測

Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 309698
出版日期 內容資訊 英文 85 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球骨·關節的再生醫療市場:產業分析·規模·佔有率·成長率與趨勢與預測 Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年07月01日 內容資訊: 英文 85 Pages
簡介

根據美國的國立衛生研究所(NIH)指出,再生醫療是指修復或替換因受傷或先天欠缺、疾病、年齡等而喪失的細胞及組織,而創造出功能性組織之過程,包含了幹細胞治療及組織工學、生醫材料等。再生醫療可應用於心血管系統、神經系統、整形外科相關、肌肉骨骼系統的疾病和障礙等各種應用領域。

本報告提供全球骨·關節的再生醫療市場相關調查,提供您再生醫療的各種部門和概要,推動市場成長的要素與阻礙要素及市場機會分析,技術部門·用途·地區別的市場成長預測,新加入廠商經營者及現有經營者的建議,主要經營者簡介,產品系列,產業策略等。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 概要
  • 市場促進因素
  • 市場成長的阻礙要素
  • 市場機會
  • 波特的五力分析
  • 競爭環境
  • 市場魅力度分析

第4章 骨·關節的再生醫療市場:各技術

  • 簡介
  • 幹細胞治療
  • 生醫材料
  • 組織工程

第5章 骨·關節的再生醫療市場:各用途

  • 概要
  • 人工骨替代材料
  • 骨關節疾病
  • 同種異體骨
  • 自體骨
  • 其他

第6章 骨·關節的再生醫療市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第7章 建議

  • 促使成長的市場策略
    • 為了產品創新的嚴密的R&D計劃
    • 新興國家的投資
  • 障礙與未來的預測
    • 幹細胞治療相關道德性課題阻礙市場的成長

第8章 企業簡介

  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Baxter International, Inc.
  • CONMED Corporation
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Holdings, Inc.
    • 產業概要
    • 財務概要
    • 產品系列
    • 產業策略
    • 最近的配合措施

圖表

目錄

Title: Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. This research report explains various advancements occurring in this market and analyzes the global regenerative medicine (bone and joint) market by technology and application as well as geographic region. The regenerative medicine (bone and joint) market report comprises an elaborate executive summary, which includes market snapshot that provides overall information of various segments and sub-segments that are contained in the report. Comparative analysis has also been included in the executive summary that resembles the percentage market share of each region (North America, Europe, Asia-Pacific, RoW) in 2012 and 2019 respectively.

The global market for regenerative medicine is segmented based on technology into stem cell therapy, biomaterials and tissue engineering. The market for these technologies has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the technologies. The market size and forecast in terms of USD million for each technology type has been provided for the period 2011 to 2019. The report on the regenerative medicine (bone and joint) market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application into bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. The market for these applications of regenerative medicine (bone and joint) has been extensively analyzed based on surgeries performed, sales revenue of the required devices and their geographic distribution. The market size and forecast in terms of USD million for each application has been provided for the period 2011 to 2019. The report on the regenerative medicine (bone and joint) market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

Market size estimations involved in-depth study of demand of regenerative medicine bone and joint products in hospitals, clinics and research organizations and average price range of each segment. Additionally, disease prevalence, geographic presence and historical year-on-year growth has been taken into consideration for calculating the market size. The market size estimated for each category is based on secondary data obtained for all the above factors cumulatively. The data obtained from secondary research was analyzed extensively and has been validated with the help of industry experts in order to arrive at the most accurate market size estimations.

Geographically, the regenerative medicine (bone and joint) market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global regenerative medicine (bone and joint) market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter's five forces analysis, and key players' market share analysis in 2012 in the regenerative medicine market for bone and joint applications.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report also profiles major players in the regenerative medicine (bone and joint) market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Anika Therapeutics, Inc., Arthrex, Inc., Baxter International, Inc., CONMED Corporation, DePuy Synthes, Inc., Medtronic, Inc., Smith & Nephew PLC, Stryker Corporation and Zimmer Holdings, Inc.

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering

Regenerative Medicine (Bone and Joint) Market, by Application

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others

Regenerative Medicine (Bone and Joint) Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Assumptions
  • 1.4. List of Abbreviations

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019)
  • 2.2. Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million)
  • 2.3. Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)

Chapter 3 - Market Overview

  • 3.1. Overview
  • 3.2. Market Drivers
    • 3.2.1. Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products
    • 3.2.2. Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products
    • 3.2.3. Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market
  • 3.3. Restraints
    • 3.3.1. Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market
    • 3.3.2. Ethical issues and post implantation infections are hindering overall market growth
  • 3.4. Opportunities
    • 3.4.1. Capitalization on the potential presented by emerging markets in Asia Pacific
  • 3.5. Porter's Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat of new entrants
    • 3.5.4. Threat of substitutes
    • 3.5.5. Competitive rivalry
  • 3.6. Competitive Landscape
    • 3.6.1. Market Share Analysis by Key Players, 2012 (Value %)
  • 3.7. Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography

Chapter 4 - Regenerative Medicine (Bone and Joint) Market, by Technology

  • 4.1. Introduction
    • 4.1.1. Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • 4.2. Stem Cell Therapy
    • 4.2.1. Global Stem Cell Therapy Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Biomaterials
    • 4.3.1. Global Biomaterials Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Tissue Engineering
    • 4.4.1. Global Tissue Engineering Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Regenerative Medicine (Bone and Joint) Market, by Applications

  • 5.1. Overview
    • 5.1.1. Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • 5.2. Bone Graft Substitutes
    • 5.2.1. Global Bone Graft Substitute Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.3. Osteoarticular Diseases
    • 5.3.1. Global Osteoarticular Diseases Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.4. Allogeneic Bones
    • 5.4.1. Global Allogenic Bones Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.5. Autogenic Bones
    • 5.5.1. Global Autogenic Bone Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Application Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 - Regenerative Medicine (Bone and Joint) Market, by Geography

  • 6.1. Overview
    • 6.1.1. Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • 6.4. Asia-Pacific
    • 6.4.1. Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

  • 7.1. Market Strategy for Success
    • 7.1.1. Rigorous research and development initiatives for innovative products
    • 7.1.2. Investing in emerging economies
  • 7.2. Barriers and Future Assumptions
    • 7.2.1. Ethical issues pertaining to stem cell therapy hampering market growth

Chapter 8 - Company Profiles

  • 8.1. Anika Therapeutics, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. Arthrex, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. Baxter International, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. CONMED Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
    • 8.4.5. Recent Developments
  • 8.5. DePuy Synthes, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
    • 8.5.5. Recent Developments
  • 8.6. Medtronic, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. Smith & Nephew plc
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. Stryker Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Zimmer Holdings, Inc.
    • 8.9.1. Business Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments

List of Figures

  • FIG. 1: Regenerative Medicine (Bone and Joint): Market Segmentation
  • FIG. 2: Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million)
  • FIG. 3: Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 4: Porter's Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market
  • FIG. 5: Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)
  • FIG. 6: Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%)
  • FIG. 7: Global Stem Cell Therapy Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 8: Global Biomaterials Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9: Global Tissue Engineering Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: Global Bone Graft Substitute Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: Global Osteoarticular Diseases Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Global Allogeneic Bones Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Global Autogenic Bone Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: Global Others Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16: Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17: Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18: RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19: Anika Therapeutics, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 20: Baxter International, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 21: Conmed Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22: Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 23: Medtronic, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24: Smith & Nephew PLC: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25: Stryker Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26: Zimmer Holdings. Inc,: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1: List of Abbreviations
  • TABLE 2: Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019)
  • TABLE 3: Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • TABLE 4: Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • TABLE 5: Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top